Skip to main content
Journal cover image

Combination Therapy for MRSA Bacteremia: To ß or Not to ß?

Publication ,  Journal Article
Holland, TL; Davis, JS
Published in: Clin Infect Dis
June 24, 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

June 24, 2020

Volume

71

Issue

1

Start / End Page

11 / 13

Location

United States

Related Subject Headings

  • beta-Lactams
  • Staphylococcal Infections
  • Retrospective Studies
  • Microbiology
  • Methicillin-Resistant Staphylococcus aureus
  • Humans
  • Daptomycin
  • Cohort Studies
  • Bacteremia
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Holland, T. L., & Davis, J. S. (2020). Combination Therapy for MRSA Bacteremia: To ß or Not to ß? Clin Infect Dis, 71(1), 11–13. https://doi.org/10.1093/cid/ciz750
Holland, Thomas L., and Joshua S. Davis. “Combination Therapy for MRSA Bacteremia: To ß or Not to ß?Clin Infect Dis 71, no. 1 (June 24, 2020): 11–13. https://doi.org/10.1093/cid/ciz750.
Holland TL, Davis JS. Combination Therapy for MRSA Bacteremia: To ß or Not to ß? Clin Infect Dis. 2020 Jun 24;71(1):11–3.
Holland, Thomas L., and Joshua S. Davis. “Combination Therapy for MRSA Bacteremia: To ß or Not to ß?Clin Infect Dis, vol. 71, no. 1, June 2020, pp. 11–13. Pubmed, doi:10.1093/cid/ciz750.
Holland TL, Davis JS. Combination Therapy for MRSA Bacteremia: To ß or Not to ß? Clin Infect Dis. 2020 Jun 24;71(1):11–13.
Journal cover image

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

June 24, 2020

Volume

71

Issue

1

Start / End Page

11 / 13

Location

United States

Related Subject Headings

  • beta-Lactams
  • Staphylococcal Infections
  • Retrospective Studies
  • Microbiology
  • Methicillin-Resistant Staphylococcus aureus
  • Humans
  • Daptomycin
  • Cohort Studies
  • Bacteremia
  • 3202 Clinical sciences